Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Erlotinib
Locations
5
Canada
Tom Baker Cancer Centre
Calgary, Alberta, Canada
Cross Cancer Institute
Edmonton, Alberta, Canada
British Columbia Cancer Agency
Vancouver, British Columbia, Canada
CancerCare Manitoba
Winnipeg, Manitoba, Canada
Princess Margaret Hospital
Toronto, Ontario, Canada
Start Date
November 1, 2006
Primary Completion Date
December 1, 2008
Completion Date
June 1, 2013
Last Updated
May 30, 2019
NCT05691465
NCT05692635
NCT04550494
NCT04929028
NCT05372640
NCT05702398
Lead Sponsor
University Health Network, Toronto
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions